BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 38730639)

  • 1. Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas.
    Naddeo M; Broseghini E; Venturi F; Vaccari S; Corti B; Lambertini M; Ricci C; Fontana B; Durante G; Pariali M; Scotti B; Milani G; Campione E; Ferracin M; Dika E
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Coding RNA Investigations in Cutaneous Melanoma: A Step forward in Discovering Novel Biomarkers.
    Ribero S; Lambertini M; Ferracin M; Dika E
    J Invest Dermatol; 2023 Apr; 143(4):531-532. PubMed ID: 36841674
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of miRNA in Melanoma Development and Progression.
    Poniewierska-Baran A; Słuczanowska-Głąbowska S; Małkowska P; Sierawska O; Zadroga Ł; Pawlik A; Niedźwiedzka-Rystwej P
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
    DiVincenzo MJ; Schwarz E; Ren C; Barricklow Z; Moufawad M; Yu L; Fadda P; Angell C; Sun S; Howard JH; Chung C; Slingluff C; Gru AA; Kendra K; Carson WE
    J Invest Dermatol; 2023 Apr; 143(4):630-638.e3. PubMed ID: 36202232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma.
    Loras A; Gil-Barrachina M; Marqués-Torrejón MÁ; Perez-Pastor G; Martinez-Cadenas C
    Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic nevi and melanoma: microRNAs tell a divergent story.
    Durante G; Veronesi G; Misciali C; Riefolo M; Lambertini M; Tartari F; Ricci C; Ferracin M; Dika E
    Pathol Res Pract; 2022 Jul; 235():153942. PubMed ID: 35594599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
    Durante G; Broseghini E; Comito F; Naddeo M; Milani M; Salamon I; Campione E; Dika E; Ferracin M
    Expert Rev Mol Diagn; 2022 Mar; 22(3):305-318. PubMed ID: 35235479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1227 Targets SEC23A to Regulate the Shedding of Large Extracellular Vesicles.
    Chin A; Mariscal J; Kim M; Guerra G; Victor B; Qian C; Broseghini E; Posadas E; Freeman MR; Sharma S; Gandellini P; Zaffaroni N; You S; Chan KS; Guarnerio J; Fabbri M; Di Vizio D
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells.
    Pegoraro A; De Marchi E; Ferracin M; Orioli E; Zanoni M; Bassi C; Tesei A; Capece M; Dika E; Negrini M; Di Virgilio F; Adinolfi E
    Cell Death Dis; 2021 Nov; 12(12):1088. PubMed ID: 34789738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Isoforms Contribution to Melanoma Pathogenesis.
    Broseghini E; Dika E; Londin E; Ferracin M
    Noncoding RNA; 2021 Sep; 7(4):. PubMed ID: 34698264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNA dysregulation in skin cancers.
    Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
    Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The WHO 2018 Classification of Cutaneous Melanocytic Neoplasms: Suggestions From Routine Practice.
    Ferrara G; Argenziano G
    Front Oncol; 2021; 11():675296. PubMed ID: 34277420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular landscape of Hereditary Melanoma.
    Ribeiro Moura Brasil Arnaut J; Dos Santos Guimarães I; Evangelista Dos Santos AC; de Moraes Lino da Silva F; Machado JR; de Melo AC
    Crit Rev Oncol Hematol; 2021 Aug; 164():103425. PubMed ID: 34245855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies.
    Scatena C; Murtas D; Tomei S
    Front Oncol; 2021; 11():635488. PubMed ID: 34123788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic classification and prognostic factors of melanoma: a 2021 update.
    Bobos M
    Ital J Dermatol Venerol; 2021 Jun; 156(3):300-321. PubMed ID: 33982546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis.
    Dika E; Broseghini E; Porcellini E; Lambertini M; Riefolo M; Durante G; Loher P; Roncarati R; Bassi C; Misciali C; Negrini M; Rigoutsos I; Londin E; Patrizi A; Ferracin M
    Cell Death Dis; 2021 May; 12(5):473. PubMed ID: 33980826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse roles of EV-RNA in cancer progression.
    Cocks A; Martinez-Rodriguez V; Del Vecchio F; Schukking M; Broseghini E; Giannakopoulos S; Fabbri M
    Semin Cancer Biol; 2021 Oct; 75():127-135. PubMed ID: 33440245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtyping Cutaneous Melanoma Matters.
    El Sharouni MA; van Diest PJ; Witkamp AJ; Sigurdsson V; van Gils CH
    JNCI Cancer Spectr; 2020 Dec; 4(6):pkaa097. PubMed ID: 33409460
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.